Contents

Clinical Cancer Drugs, Volume 3 - Number 1


Editorial


Prostate Cancer Molecular Background: The IGF-1Ec Story

, 3(1): 6 - 15

Armakolas Athanasios and Koutsilieris Michael


DOI: 10.2174/2212697X03666151203202720



Castration-resistant Prostate Cancer: The Targeting of Bone Microenvironment-related Survival Factors For Prostate Cancer Cells

, 3(1): 16 - 22

Dimitrios Karamanolakis, Athanasios Armakolas and Michael Koutsilieris


DOI: 10.2174/2212697X03666151203202934



Targeting Epigenome As An Innovative Pharmacological Strategy For Castration-resistant Prostate Cancer

, 3(1): 23 - 35

Lavinia Casati, Fabio Celotti and Valeria Sibilia


DOI: 10.2174/2212697X03666151207185452



Targeting the PI3K/AKT/mTOR Pathway in Prostate Cancer Development and Progression: Insight to Therapy

, 3(1): 36 - 62

Festuccia Claudio


DOI: 10.2174/2212697X0301160328201324



Medicinal Compound Celastrol As a Potential Clinical Anticancer Drug: Lessons Learned From Preclinical Studies

, 3(1): 63 - 73

Jianquan Wu, Chengcheng Hong, Hongjie Pan, Qingzhu Yang, Yu Mei, Q. Ping Dou and Huanjie Yang


DOI: 10.2174/2212697X03666160112001739




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science